UCSF

ZINC00004840

Substance Information

In ZINC since Heavy atoms Benign functionality
September 26th, 2005 19 Yes

CAS Numbers: 75706-12-6 , [75706-12-6]

Other Names:

210165-51-8

4-Isoxazolecarboxamide, 5-methyl-N-(4-(trifluoromethyl)phenyl

4-Isoxazolecarboxamide, 5-methyl-N-(4-(trifluoromethyl)phenyl)-

4-Isoxazolecarboxamide, 5-methyl-N-(4-(trifluoromethyl)phenyl)-; 4-isoxazolecarboxamide,5-methyl-N-(4-(trifluoromethyl)phenyl); 5-Methyl-N-(4-(trifluoromethyl)phenyl)-4-isoxazolecarboxamide; 5-Methylisoxazole-4-carboxylic acid (4-trifluoromethyl)anilide

4-Isoxazolecarboxamide, 5-methyl-N-[4-(trifluoromethyl)phenyl]-

4-isoxazolecarboxamide,5-methyl-N-(4-(trifluoromethyl)phenyl)

5-Methyl-N-(4-(trifluoromethyl)phenyl)-4-isoxazolecarboxamide

5-Methyl-N-(4-(trifluoromethyl)phenyl)-4-isoxazolecarboxamide; 5-Methylisoxazole-4-carboxylic acid (4-trifluoromethyl)anilide; Leflunomide; alpha,alpha,alpha-Trifluoro-5-methyl-4-isoxazolecarboxy-p-toluidide

5-Methyl-N-[4-(trifluoromethyl)-phenyl]isoxazole-4-carboxamide

5-methyl-N-[4-(trifluoromethyl)phenyl]-1,2-oxazole-4-carboxamide

5-methyl-N-[4-(trifluoromethyl)phenyl]-4-isoxazolecarboxamide

5-methyl-N-[4-(trifluoromethyl)phenyl]isoxazole-4-carboxamide

5-Methylisoxazole-4-(4-trifluoromethyl)carboxanilide

5-METHYLISOXAZOLE-4-(4-TRIFLUOROMETHYLCARBOXANILID

5-Methylisoxazole-4-(4-trifluoromethylcarboxanilide)

5-Methylisoxazole-4-carboxylic acid (4-trifluoromethyl)anilide

75706-12-6

75706-12-6; Arava (TN); D00749; Leflunomide (JAN/USAN/INN)

75706-12-6; C07905; Leflunomide

75706-12-6; Leflunomide; Prestwick_87

A77 1486

AB00052389

AC-6796

AC1L1GYK

AC1Q2EVA

AKOS000265193

alpha,alpha,alpha-Trifluoro-5-methyl-4-isoxazolecarboxy-p-toluidide

AP-501/42475599

Arava

Arava (TN)

Arava, Leflunomide

Aventis Behring Brand of Leflunomide

Aventis Brand of Leflunomide

Aventis Pharma Brand of Leflunomide

BAN

BIDD:PXR0189

BPBio1_000930

BRD-K78692225-001-03-9

BSPBio_000844

C045463

C07905

CAS-75706-12-6

CHEBI:6402

CHEMBL960

CID3899

D00749

DAP000636

DB01097

DivK1c_000916

EU-0100649

FDA

HMS1570K06

HMS1922M06

HMS2090O12

HMS502N18

Hoechst Brand of Leflunomide

HSDB 7289

HWA 486

HWA-486

HWA-486; SU-101; Sulol

I06-2131

IDI1_000916

INN

Isoxazole-4-carboxamide, 5-methyl-N-[4-(trifluoromethyl)phenyl]-

KBio1_000916

KBio2_000802

KBio2_003370

KBio2_005938

KBioSS_000802

L 5025

L5025_SIGMA

Leflunomid

Leflunomida

Leflunomida [INN-Spanish]

leflunomida; leflunomide; leflunomidum

Leflunomide (BAN

Leflunomide (FDA

Leflunomide (JAN/USAN/INN)

Leflunomide [USAN:INN]

Leflunomidum

Leflunomidum [INN-Latin]

Leflunomidum [INN-Latin];Lefunomide [INN-Spanish]

lefunamide

Lefunomide [INN-Spanish]

LS-86580

MFCD00867593

MLS-0003109.0001

MLS000069648

MLS001076267

MolPort-002-345-613

N-(4'-Trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide

N-(4-trifluoromethyphenyl)-5-methylisoxazole-4-carboxamide

NCGC00015610-01

NCGC00015610-02

NCGC00015610-03

NCGC00015610-07

NCGC00015610-12

NCGC00022625-03

NCGC00022625-04

NCGC00022625-05

NCGC00022625-06

NCGC00022625-07

NCGC00022625-08

NINDS_000916

NSC677411

Prestwick0_000772

Prestwick1_000772

Prestwick2_000772

Prestwick3_000772

Prestwick_87

Repso

RS-34821

S1247_Selleck

SMR000058209

SPBio_002783

SPECTRUM1503927

Spectrum5_000850

Spectrum_000322

SU 101

SU 101 (pharmaceutical)

SU-101

SU101

TL8005179

UNII-G162GK9U4W

USAN)

ZINC00004840

Download: MOL2 SDF SMILES Flexibase

Annotations

Vendors

Physical Representations

Type pH range xlogP Des A‑Pol Apolar desolvation (kcal/mol) Des Pol Polar desolvation (kcal/mol) H Don H-bond donors H Acc H-bond acceptors Chg Net charge tPSA (Ų) MWT Molecular weight (g/mol) RB Rotatable bonds DL
Ref Reference (pH 7) 2.36 5.4 -9.87 1 4 0 55 270.21 3

Vendor Notes

Note Type Comments Provided By
ALOGPS_SOLUBILITY 8.44e-02 g/l DrugBank-approved
purity 9.500000000000000e+001 Enamine Building Blocks Enamine Building Blocks
Purity 99% APIChem
Therapy antineoplastic, PDGF receptor blocker SMDC Iconix
Target Dehydrogenase Selleck Chemicals
Patent Database Links EP0956855; EP1176140; EP1229034; EP1310488; EP1382339; EP1471054; EP1473035; EP1516597; EP1543839; EP1623709; EP1686130; EP1712220; EP1769807; EP1808177; EP1815867; EP1894559; EP1920772; EP1925941; EP1990048; US2004082664; US2004152772; US2004261190; US20 ChEBI
UniProt Database Links HUT1_YEAST; MLF3_YEAST; SSH4_YEAS7; SSH4_YEAST ChEBI
Indications immunosuppressive KeyOrganics Bioactives
Target Others Selleck Chemicals
Indications psoriatic & rheumatoid arthritis KeyOrganics Bioactives

Activity (Go SEA)

Clustered Target Annotations
Code Description Organism Class Affinity (nM) LE (kcal/mol/atom) Type
PYRD-1-E Dihydroorotate Dehydrogenase (cluster #1 Of 1), Eukaryotic Eukaryotes 9 0.59 Binding ≤ 10μM
Z50587-1-O Homo Sapiens (cluster #1 Of 9), Other Other 5400 0.39 Functional ≤ 10μM
Z50594-1-O Mus Musculus (cluster #1 Of 9), Other Other 9600 0.37 Functional ≤ 10μM
Z50597-1-O Rattus Norvegicus (cluster #1 Of 12), Other Other 1000 0.44 Functional ≤ 10μM
ChEMBL Target Annotations
Uniprot Swissprot Description Affinity (nM) LE (kcal/mol/atom) Type
PYRD_RAT Q63707 Dihydroorotate Dehydrogenase, Rat 9 0.59 Binding ≤ 1μM
PYRD_MOUSE O35435 Dihydroorotate Dehydrogenase, Mouse 30 0.55 Binding ≤ 1μM
PYRD_RAT Q63707 Dihydroorotate Dehydrogenase, Rat 1600 0.43 Binding ≤ 10μM
PYRD_HUMAN Q02127 Dihydroorotate Dehydrogenase, Human 10000 0.37 Binding ≤ 10μM
PYRD_MOUSE O35435 Dihydroorotate Dehydrogenase, Mouse 30 0.55 Binding ≤ 10μM
Z50587 Z50587 Homo Sapiens 5400 0.39 Functional ≤ 10μM
Z50594 Z50594 Mus Musculus 10000 0.37 Functional ≤ 10μM
Z50597 Z50597 Rattus Norvegicus 1000 0.44 Functional ≤ 10μM

Reactome Annotations from Targets (via Uniprot)

Description Species
Pyrimidine biosynthesis

Analogs ( Draw Identity 99% 90% 80% 70% )

No pre-computed analogs available. Try a structural similarity search.